Current GPC3-based BsAbs exemplified by ERY974 (GPC3/CD3) predominantly employ T cell recruitment strategies, yet confront challenges including cytokine release syndrome (CRS) and T cell exhaustion (20, 21). Here, GPC3 is linked to congenital rubella syndrome.